| __timestamp | Axsome Therapeutics, Inc. | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4279200 | 5280000 |
| Thursday, January 1, 2015 | 6776987 | 7148000 |
| Friday, January 1, 2016 | 21199860 | 19594000 |
| Sunday, January 1, 2017 | 19957616 | 22894000 |
| Monday, January 1, 2018 | 23495055 | 50337000 |
| Tuesday, January 1, 2019 | 53647067 | 109450000 |
| Wednesday, January 1, 2020 | 70244579 | 90450000 |
| Friday, January 1, 2021 | 58060725 | 104128000 |
| Saturday, January 1, 2022 | 57947447 | 108630000 |
| Sunday, January 1, 2023 | 97944000 | 134951000 |
Unleashing insights
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Axsome Therapeutics, Inc. and Rhythm Pharmaceuticals, Inc. have demonstrated significant investment in R&D, reflecting their dedication to advancing medical science.
From 2014 to 2023, Axsome Therapeutics increased its R&D expenses by over 2,000%, peaking in 2023 with a remarkable 98 million dollars. This growth underscores their strategic focus on developing novel therapies for central nervous system disorders.
Similarly, Rhythm Pharmaceuticals has shown a robust R&D trajectory, with a 2,500% increase over the same period, reaching 135 million dollars in 2023. Their investment highlights a strong commitment to addressing rare genetic disorders.
Both companies exemplify the biotech industry's relentless pursuit of innovation, with R&D spending reflecting their strategic priorities and potential for future breakthroughs.
Research and Development Expenses Breakdown: Novartis AG vs Rhythm Pharmaceuticals, Inc.
Comparing Innovation Spending: Amgen Inc. and Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Axsome Therapeutics, Inc.
Analyzing R&D Budgets: Vertex Pharmaceuticals Incorporated vs Rhythm Pharmaceuticals, Inc.
R&D Spending Showdown: Neurocrine Biosciences, Inc. vs Rhythm Pharmaceuticals, Inc.
Research and Development Investment: Bio-Techne Corporation vs Rhythm Pharmaceuticals, Inc.
Research and Development Investment: Madrigal Pharmaceuticals, Inc. vs Rhythm Pharmaceuticals, Inc.
Analyzing R&D Budgets: Opthea Limited vs Rhythm Pharmaceuticals, Inc.
Research and Development Investment: Axsome Therapeutics, Inc. vs Alpine Immune Sciences, Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.